Skip to main content
Sign In


The Rheumatology Division at the University of Colorado has numerous ongoing clinical research studies. Our human research studies are divided into two main areas: 

1) Treatment trials which involve the use of new therapies for disease

2) Studies on the development and prevention of diseases such as rheumatoid arthritis and lupus

Currently enrolling:

  •  Complement Receptor 2 as a Biomarker for Systemic Lupus Erythematosus
  •  Role of Complement Receptor 2 in systemic lupus Erthymatosus 




For more information on any of our studies, please try the following links:




      • Rheumatoid arthritis
      • Psoriatic arthritis
      • Lupus
      • Other rheumatologic disease




      • Sera Study
        • SERA is identifying established and new, potentially important blood and genetic markers.
        • SERA is looking for the presence of various autoantibodies* in the blood of healthy people. These autoantibodies may be present before physical symptoms of the disease are evident. 
        • SERA is also looking at possible environmental factors that could contribute to RA.
        • SERA’s findings may lead to earlier diagnosis, and possible prevention of RA in the future.